Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale

Drug and Alcohol Dependence

Volumn 159, Issue , 2016, Pages 42-52

  Larance, Briony ^a   Bruno, Raimondo ^b   Lintzeris, Nicholas ^c,d   Degenhardt, Louisa ^a,e,f,g   Black, Emma ^a   Brown, Amanda ^h   Nielsen, Suzanne ^a,d   Dunlop, Adrian ^h,i   Holland, Rohan ^h   Cohen, Milton ^j   Mattick, Richard P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g UNIVERSITY OF WASHINGTON   (United States)

^h Drug Alcohol Clinical Services   (Australia)

ⁱ UNIVERSITY OF NEWCASTLE   (Australia)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

more..

Author keywords

Addiction; Chronic pain; Medication non adherence; Opioid analgesics; Opioid substitution therapy

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ARTICLE; CORRELATIONAL STUDY; DEPRESSION; DRUG MONITORING; FACE VALIDITY; FEMALE; HUMAN; LONG TERM CARE; MALE; OPIATE SUBSTITUTION TREATMENT; OPIOID RELATED BEHAVIORS IN TREATMENT SCALE; PAIN; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; STRESS; TEST RETEST RELIABILITY; ADULT; ADVERSE EFFECTS; AGED; MIDDLE AGED; OPIOID-RELATED DISORDERS; PROBLEM BEHAVIOR; PSYCHOLOGY; REPRODUCIBILITY;

ADULT; AGED; ANALGESICS, OPIOID; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROBLEM BEHAVIOR; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 84955188618     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.11.026     Document Type: Article

References (56)

1. Adams L., Gatchel R., Robinson R., Polatin P., Gajraj N., Deschner M., Noe C. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J. Pain Symptom Manage. 2004, 27:440-459.
2. Atluri S.L., Sudarshan G. Development of a screening tool to detect the risk of inappropriate prescription opioid use in patients with chronic pain. Pain Physician 2004, 7:333-338.
3. Banta-Green C.J., Von Korff M., Sullivan M.D., Merrill J.O., Doyle S.R., Saunders K. The prescribed opioids difficulties scale: a patient-centered assessment of problems and concerns. Clin. J. Pain 2010, 26:489-497.
4. Belgrade M.J., Schamber C.D., Lindgren B.R. The DIRE Score: predicting outcomes of opioid prescribing for chronic pain. J. Pain 2006, 7:671-681.
5. Bush K., Kivlahan D.R., McDonell M.B., Fihn S.D., Bradley K.A. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch. Intern. Med. 1998, 158:1789-1795.
6. Butler S., Budman S., Fanciullo G., Jamison R. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin. J. Pain 2010, 26:770-776.
7. Butler S., Budman S., Fernandez K., Fanciullo G., Jamison R. Cross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R). J. Addict. Med. 2009, 3:66.
8. Butler S., Budman S., Fernandez K., Houle B., Benoit C., Katz N., Jamison R. Development and validation of the current opioid misuse measure. Pain 2007, 130:144.
9. Butler S.F., Budman S.H., Fernandez K., Jamison R.N. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004, 112:65-75.
10. Butler S.F., Budman S.H., Fernandez K.C., Houle B., Benoit C., Katz N., Jamison R.N. Corrigendum to "Development and validation of the current opioid misuse measure" [Pain 130 (2007) 144-156]. Pain 2009, 142:169.
11. Butler S.F., Fernandez K., Benoit C., Budman S.H., Jamison R.N. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J. Pain 2008, 9:360-372.
12. Campbell G., Mattick R., Bruno R., Larance B., Nielsen S., Cohen M., Lintzeris N., Shand F., Hall W.D., Hoban B., Kehler C., Farrell M., Degenhardt L. Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study. BMC Pharmacol. Toxicol. 2014, 15:17. 10.1186/2050-6511-1115-1117.
13. Campbell G., Nielsen S., Larance B., Bruno R., Mattick R., Hall W., Lintzeris N., Cohen M., Smith K., Degenhardt L. Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the Pain and Opioids in Treatment (POINT) Cohort. Pain Med. 2015, [Epub ahead of print]. 10.1111/pme.12773.
14. Chabal C., Erjavec M., Jacobson L., Mariano A., Chaney E. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin. J. Pain 1997, 13:150.
15. Chou R., Fanciullo G.J., Fine P.G., Miaskowski C., Passik S.D., Portenoy R.K. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J. Pain 2009, 10:131-146.
16. Clark L.A., Watson D. Constructing validity: basic issues in objective scale development. Psychol. Assess. 1995, 7:309-319.
17. Coambs R., Jarry J., Santhiapillai A., Abrahamsohn R., Atance C. The SISAP: a new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain within general medical practice. Pain Res. Manage. 1996, 1:155-162.
18. Coluzzi F., Pappagallo M. Opioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapy. Minerva Anestesiol. 2005, 71:425-433. on behalf of the National Initiative on Pain Control.
19. Compton P., Darakjian J., Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. J. Pain Symptom Manage. 1998, 16:355-363.
20. Compton P.A., Wu S.M., Schieffer B., Pham Q., Naliboff B.D. Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J. Pain Symptom Manage. 2008, 36:383-395.
21. Compton W.M., Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006, 81:103-107.
22. Cowan D.T., Allan L.G., Libretto S.E., Griffiths P. Opioid drugs: a comparative survey of therapeutic and "street" use. Pain Med. 2001, 2:193-203.
23. Cowan D.T., Wilson-Barnett J., Griffiths P., Allan L.G. survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med. 2003 a, 4:340-351.
24. de las Cuevas C., Sanz E.J., de la Fuente J.A., Padilla J., Berenguer J.C. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 2000, 95:245-250.
25. Elander J., Lusher J., Bevan D., Telfer P. Pain management and symptoms of substance dependence among patients with sickle cell disease. Soc. Sci. Med. 2003, 57:1683-1696.
26. Fleming M.F., Davis J., Passik S.D. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med. 2008, 9:1098-1106.
27. Friedman R., Li V., Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med. 2003, 4:182-185.
28. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995, 90:607-614.
29. Hays R.D., Morales L.S., Reise S.P. Item response theory and health outcomes measurement in the 21st century. Med. Care 2000, 38:II28-II42.
30. Holmes C.P., Gatchel R.J., Adams L.L., Stowell A.W., Hatten A., Noe C., Lou L. An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire. Pain Pract. 2006, 6:74-88.
31. Knisely J.S., Wunsch M.J., Cropsey K.L., Campbell E.D. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse. J. Subst. Abuse Treat. 2008, 35:380-386.
32. Lovibond P.F., Lovibond S.H. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav. Res. Ther. 1995, 33:335-343.
33. Manchikanti L., Helm S., Fellows B., Janata J.W., Pampati V., Grider J.S., Boswell M.V. Opioid epidemic in the United States. Health Policy Rev. 2012, 15:ES9-ES38.
34. Manchikanti L., Singh V., Damron K.S., Beyer C.D., Pampati V. Screening for controlled substance abuse in an interventional pain management setting: evaluation of an assessment tool. Pain Physician 2003, 6:425-433.
35. Marel C., Mills K., Darke S., Ross J., Burns L., Teesson M. Can we predict retention in longitudinal studies of substance use? Findings from the Australian Treatment Outcome Study. Addict. Behav. 2015, 51:38-43.
36. McCarthy M. Opioid overdose deaths rose fivefold among US women in 10 years. BMJ 2013, 347. 10.1136/bmj.f4415.
37. Michna E., Ross E.L., Hynes W.L., Nedeljkovic S.S., Soumekh S., Janfaza D., Palombi D., Jamison R.N. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J. Pain Symptom Manage. 2004, 28:250-258.
38. Miotto K., Compton P., Ling W., Conolly M. Diagnosing addictive disease in chronic pain patients. Psychosomatics 1996, 37:223-235.
39. Nicholson B., Passik S.D. Management of chronic noncancer pain in the primary care setting. South Med. J. 2007, 100:1028-1036.
40. Passik S.D., Kirsh K.L. The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. Pain Med. 2003, 4:186-189.
41. Passik S.D., Kirsh K.L. Managing pain in patients with aberrant drug-taking behaviors. J. Support. Oncol. 2005, 3:83-86.
42. Passik S.D., Kirsh K.L., Casper D. Addiction-related assessment tools and pain management: instruments for screening, treatment planning, and monitoring compliance. Pain Med. 2008, 9:S145-S146.
43. Passik S.D., Kirsh K.L., Donaghy K.B., Portenoy R.K. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin. J. Pain 2006, 22:173-181.
44. Passik S.D., Kirsh K.L., McDonald M.V., Ahn S., Russak S.M., Martin L., Rosenfeld B., Breitbart W.S., Portenoy R.K. A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J. Pain Symptom Manage. 2000, 19:274-286.
45. Passik S.D., Kirsh K.L., Whitcomb L., Portenoy R.K., Katz N.P., Kleinman L., Dodd S.L., Schein J.R. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin. Ther. 2004, 26:552-561.
46. Paulozzi L. Prescription drug overdoses: a review. J. Safety Res. 2012, 43:283-289.
47. Reise S.P., Waller N.G. Item response theory and clinical measurement. Ann. Rev. Clin. Psychol. 2009, 5:27-48.
48. Sees K.L., Clark H.W. Opioid use in the treatment of chronic pain: assessment of addiction. J. Pain Symptom Manage. 1993, 8:257-264.
49. Smith S.M., Paillard F., McKeown A., Burke L.B., Edwards R.R., Katz N.P., Papadopoulos E.J., Rappaport B.A., Slagle A., Strain E.C., Wasan A.D., Turk D.C., Dworkin R.H. Instruments to identify prescription medication misuse, abuse, and related events in clinical trials: an ACTTION Systematic Review. J. Pain 2015, 16:389-411.
50. The WHOQOL Group Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol. Med. 1998, 28:551-558.
51. The WHOQOL Group The World Health Organization quality of life assessments (WHOQOL): development and general psychometric properties. Soc. Sci. Med. 1998, 46:1569-1585.
52. Turk D., Swanson K., Gatchel R. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin. J. Pain 2008, 24:497.
53. Webster L., Webster R. Predicting aberrant behaviors in opioid treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005, 6:432-442.
54. World Health Organization WHO Model List of Essential Medicines 2013, Essential Medicines Library. http://www.who.int/medicines/publications/essentialmedicines/en/index.html, 18th ed.
55. Worthington R.L., Whittaker R.A. Scale development research: a content analysis and recommendations for best practices. Couns. Psychol. 2006, 34:806-838.
56. Wu S.M., Compton P., Bolus R., Schieffer B., Pham Q., Baria A., Van Vort W., Davis F., Shekelle P., Naliboff B.D. The Addiction Behaviors Checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J. Pain Symptom Manage. 2006, 32:342-351.